scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM199105023241804 |
P698 | PubMed publication ID | 1849612 |
P2093 | author name string | Berry S | |
Corey L | |||
Burchett S | |||
Benedetti J | |||
Ashley R | |||
Brown ZA | |||
Selke S | |||
Vontver LA | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
Neonatal herpes simplex | Q3134326 | ||
P304 | page(s) | 1247-1252 | |
P577 | publication date | 1991-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor | |
P478 | volume | 324 |
Q57076555 | 4 Herpes simplex virus infection in pregnancy |
Q33936150 | A comparison of referral patterns and characteristics of patients with first episode symptomatic genital HSV-1 and HSV-2 infections in Sheffield. |
Q35200947 | A review of common pediatric lip lesions: herpes simplex/recurrent herpes labialis, impetigo, mucoceles, and hemangiomas |
Q45734471 | A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel |
Q42162395 | Acute retinal necrosis diagnosed in a child with chronic panuveitis |
Q37188380 | An HSV-1 gD mutant virus as an entry-impaired live virus vaccine |
Q34549656 | An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. |
Q36740192 | Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms |
Q24239986 | Antiviral agents for treatment of herpes simplex virus infection in neonates |
Q24250099 | Antiviral agents for treatment of herpes simplex virus infection in neonates |
Q36162365 | Antiviral therapy for genital herpes infections in pregnancy |
Q33856050 | Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes |
Q45770740 | Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology |
Q36624960 | Cervical antibodies to herpes simplex virus proteins in pregnancy and puerperium: a pilot study |
Q36625212 | Cesarean delivery in women with genital herpes in washington state, 1989-1991. |
Q45402225 | Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice |
Q34918343 | Clinical manifestations and treatment considerations of herpes simplex virus infection |
Q40637748 | Common skin problems during the first year of life. |
Q34127423 | Current recommendations for the treatment of genital herpes. |
Q22306018 | Current treatment options to prevent perinatal transmission of herpes simplex virus |
Q40669557 | Cutaneous neonatal herpes simplex virus infection type 2: a case report |
Q36528531 | Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes |
Q36192705 | Diagnosis of herpes simplex virus infections of the CNS. |
Q36463219 | Diagnostics for herpes simplex virus: is PCR the new gold standard? |
Q58815038 | Directive clinique sur la prise en charge du virus de l’herpès simplex pendant la grossesse |
Q36570266 | Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes |
Q40199351 | Disseminated Neonatal Herpes Simplex Virus Type 1 After a Water Birth |
Q45754732 | Disseminated herpes simplex virus infection in a neonate |
Q44713011 | Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation. |
Q35615310 | Do antepartum herpes simplex virus cultures predict intrapartum shedding for pregnant women with recurrent disease? |
Q33574240 | Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure |
Q41533140 | Enzyme-assisted extraction of bioactive material from Chondrus crispus and Codium fragile and its effect on herpes simplex virus (HSV-1). |
Q34446935 | Epidemiological impact of a genital herpes type 2 vaccine for young females |
Q35007321 | Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa |
Q35530369 | Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. |
Q30654285 | Evaluation of ELVIS HSV ID/Typing System for the detection and typing of herpes simplex virus from clinical specimens |
Q40257387 | Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice |
Q33959969 | Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera |
Q45783859 | Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus |
Q39302581 | Fundamentals of Clinical Pharmacology With Application for Pregnant Women |
Q28262599 | Genital herpes |
Q41665395 | Genital herpes and its treatment in relation to preterm delivery |
Q77803098 | Genital herpes complicating pregnancy |
Q41349366 | Genital herpes simplex infection in women |
Q40828445 | Genital herpes. Type-specific antibodies for diagnosis and management |
Q33975387 | Genital herpes: review of the epidemic and potential use of type-specific serology |
Q36568824 | Guidance on management of asymptomatic neonates born to women with active genital herpes lesions |
Q45393901 | Guidelines for the management of herpes simplex virus in pregnancy |
Q57269745 | HERPES |
Q42948758 | HSV type specific antibody tests: patients are ready, are clinicians? |
Q22306291 | HSV-2: in pursuit of a vaccine |
Q34435095 | Hematogenous vertical transmission of herpes simplex virus type 1 in mice |
Q68158083 | Herpes Genitalis |
Q36624483 | Herpes in pregnancy |
Q77803093 | Herpes management and prophylaxis |
Q77304582 | Herpes simplex virus |
Q35767424 | Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study |
Q45872128 | Herpes simplex virus infection in pregnancy and its management |
Q35066818 | Herpes simplex virus infection in pregnancy. |
Q33948597 | Herpes simplex virus infections |
Q40423498 | Herpes simplex virus infections in the neonate |
Q35114519 | Herpes simplex virus infections of women and their offspring: implications for a developed society |
Q45760679 | Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. |
Q41432144 | Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy |
Q44293963 | Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy |
Q34071917 | Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons |
Q35605299 | Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth |
Q41154037 | Herpes simplex: evolving concepts |
Q51647546 | Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? |
Q36113129 | High prevalence of sexually transmitted infections in pregnant adolescent girls in Tanzania: a multi-community cross-sectional study |
Q37119250 | Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot |
Q34233814 | Identification of Women at Unsuspected Risk of Primary Infection with Herpes Simplex Virus Type 2 during Pregnancy |
Q42200895 | Identification of novel virus-specific antigens by CD4⁺ and CD8⁺ T cells from asymptomatic HSV-2 seropositive and seronegative donors |
Q45752372 | IgG and IgM antibodies of Herpes Simplex Virus type-1 and type-2 in 233 maternal and neonatal sera |
Q40536085 | Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial |
Q34529794 | Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus |
Q33801850 | Improving the care of patients with genital herpes |
Q45421960 | Induction of apoptosis by herpes simplex virus-1 in neonatal, but not adult, neutrophils |
Q46973679 | Infections with herpes simplex and varicella-zoster viruses during pregnancy |
Q71626687 | Infectious diseases |
Q24815062 | Macrophages and cytokines in the early defence against herpes simplex virus |
Q33939725 | Management of neonatal herpes simplex virus infection |
Q38192811 | Management of neonatal herpes simplex virus infection and exposure |
Q39999469 | Managing genital herpes infections in pregnancy |
Q38007203 | Managing sexually transmitted infections in pregnant women |
Q45118464 | Mannan-binding lectin modulates the response to HSV-2 infection |
Q34181697 | Mother-to-Child Transmission of Herpes Simplex Virus |
Q36520832 | Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections |
Q37531713 | Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs |
Q58997173 | Neonatal Herpes Simplex Infection |
Q68251270 | Neonatal Herpes Simplex Virus Infection and Asymptomatic Maternal Infection |
Q67473756 | Neonatal Herpes Simplex: Royal Women's Hospital 10‐year Experience with Management Guidelines for Herpes in Pregnancy |
Q50560606 | Neonatal herpes in Denmark 1977-1991. |
Q42206547 | Neonatal herpes infections in The Netherlands in the period 2006-2011. |
Q40724442 | Neonatal herpes policy in The Netherlands. Five years after a consensus conference |
Q43530537 | Neonatal herpes simplex and incontinentia pigmenti |
Q35545367 | Neonatal herpes simplex infection |
Q73214960 | Neonatal herpes simplex virus infection |
Q45766195 | Neonatal herpes simplex virus infection in the British Isles |
Q34462160 | Neonatal herpes simplex virus infections |
Q36206687 | Neonatal herpes simplex virus infections: where are we now? |
Q35544375 | Neonatal sepsis: A, B, C--don't ever forget herpes |
Q33815811 | Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro |
Q33582145 | New concepts in understanding genital herpes |
Q37609430 | New management of the pregnant patient to reduce the risk of transmitting herpes to the newborn |
Q35821828 | Nucleic acid amplification technology for the diagnosis of genital herpes infection |
Q36625340 | Pathogenesis of HSV and CMV Infections in Pregnancy |
Q40903260 | Perinatal herpesvirus infections. Herpes simplex, varicella, and cytomegalovirus |
Q45880084 | Persistent cerebrospinal fluid neutrophilia in delayed-onset neonatal encephalitis caused by herpes simplex virus type 2 |
Q45783219 | Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes |
Q34027261 | Pregnancy and sexually transmitted viral infections |
Q35171671 | Prenatal testing for infectious disease |
Q35073056 | Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania |
Q35283797 | Preventing herpes simplex virus in the newborn |
Q44260237 | Prevention of and screening for herpes simplex infection: a survey of Quebec physicians |
Q36613109 | Primary Maternal Herpes Simplex Virus-1 Gingivostomatitis During Pregnancy and Neonatal Herpes: Case Series and Literature Review |
Q34918299 | Progress in meeting today's demands in genital herpes: an overview of current management |
Q33866424 | Prospects for control of herpes simplex virus disease through immunization. |
Q36546275 | Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test. |
Q37694574 | Rapid host immune response and viral dynamics in herpes simplex virus-2 infection |
Q36739105 | Recent Developments in STDs: II. Viral and Other Syndromes |
Q35893279 | Recent developments in genital herpes |
Q33963713 | Recent progress in herpes simplex virus immunobiology and vaccine research |
Q35181104 | Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. |
Q40918308 | Routine antenatal screening and prenatal diagnosis of vertically transmissible infection |
Q42948159 | Screening for herpes simplex virus in infertile women. |
Q45243170 | Screening pregnant women for genital herpes |
Q35639039 | Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology |
Q41677372 | Selected pediatric viral infections |
Q24791873 | Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study |
Q37277980 | Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics |
Q37116538 | Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay |
Q35562480 | Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy |
Q45730664 | Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection |
Q36083783 | Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India |
Q33917477 | Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya |
Q46217581 | Severe intrauterine herpes simplex disease with placentitis in a newborn of a mother with recurrent genital infection at delivery |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q45758417 | Successful treatment of herpes simplex virus (HSV) recurrent genital infection with recombinant human (rh) granulocyte-macrophage colony stimulating factor (GM-CSF): a case report |
Q36871260 | The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology |
Q34397188 | The mechanisms of placental viral infection |
Q35562954 | The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis |
Q35627572 | Treatment of sexually transmitted diseases in women |
Q41429399 | Treatment of viral infections during pregnancy and the neonatal period. |
Q67488109 | Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures |
Q44764210 | Update on the treatment of genital herpes |
Q33785271 | Update on the treatment of sexually transmitted infections in pregnancy--2. |
Q45458601 | Vacuum extraction and herpes simplex virus infection |
Q47189603 | Vagina dentata revisited: gender and asymptomatic shedding of genital herpes |
Q37424183 | Vertical transmission of genital herpes: prevention and treatment options |
Q36625515 | Vertical transmission of herpes simplex virus acquired after primary outbreak in second trimester of a dichorionic twin gestation |
Q78621493 | [Clinical management of genital herpes: what can be done in pregnancy?] |
Q79913831 | [Neonatal sepsis due to herpes simplex virus with fulminant liver failure] |
Search more.